
Keywords: اینترلوکین 1; ADA; American Diabetes Association; AR; acute rejection; ASP; acylation stimulating protein; BMI; body mass index; CMV; cytomegalovirus; DGF; delayed graft function; HCV; hepatitis C virus; IL-1; interleukine 1; IL-6; interleukin-6; IRI; immunoreactive in